TELAVANT

Pharmaceutical preparations for human use to treat Colitis ulcerosa and Morbus Crohn; biologic preparations for medical and therapeutic purposes to treat Colitis ulcerosa and Morbus Crohn; pharmaceutical preparations to treat gastrointestinal diseases and disorders and immunological diseases and disorders; biologic preparations to treat gastrointestinal diseases and disorders and immunological diseases and disorders

Scientific and technological services namely, scientific research and design in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical and biomedical research services; research in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical research and development; providing scientific research information in the field of pharmaceuticals and biomedicine; medical and scientific research, namely, conducting clinical trials for others

Providing health and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions